Pharmacokinetics, Safety and Cognitive Function Profile of Rupatadine 10, 20 and 40 mg in Healthy Japanese Subjects: A Randomised Placebo-Controlled Trial
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference31 articles.
1. Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper;MK Church;Allergy,2010
2. Pharmacological profile of the new antihistamines;J-P Tillement;Clin Exp All Rev,2005
3. Evaluation of nasal symptoms induced by platelet activating factor, after nasal challenge in both healthy and allergic rhinitis subjects pretreated with rupatadine, levocetirizine or placebo in a cross-over design;R Muñoz-Cano;Allergy Asthma Clin Immunol,2013
4. Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study;EM Guadaño;Allergy,2004
5. A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis;S Fantin;Allergy,2008
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Targeting Histamine and Histamine Receptors for Memory Regulation: An Emotional Perspective;Current Neuropharmacology;2024-09
2. Green micellar stability‐indicating high‐performance liquid chromatography method for determination of rupatadine fumarate in the presence of its main impurity desloratadine: Oxidative degradation kinetics study;Journal of Separation Science;2023-05-26
3. Rupatadine – a panacea for allergies? A literature review;Pediatria i Medycyna Rodzinna;2021-03-05
4. In vitro effects of histamine receptor 1 antagonists on proliferation and histamine release in canine neoplastic mast cells;Veterinary Medicine and Science;2020-09-13
5. Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis;Allergy, Asthma & Clinical Immunology;2020-04-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3